IDXX Q1 2025 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

Q1 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$998M+3.6% YoY

Gross Profit

$623M62.4% margin

Operating Income

$317M31.7% margin

Net Income

$243M24.3% margin

EPS (Diluted)

$2.96

QoQ Revenue Growth

+4.6%

Cash Flow

Operating Cash Flow

$238M

Free Cash Flow

$208M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$3.2B

Total Liabilities

$1.8B

Stockholders' Equity

$1.4B

Cash & Equivalents

$164M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$998M	$964M	+3.6%
Gross Profit	$623M	$593M	+5.1%
Operating Income	$317M	$299M	+5.9%
Net Income	$243M	$236M	+3.0%

Revenue Segments

Product

$573M57%

Service

$425M43%

Geographic Segments

UNITED STATES

$655M67%

EMEA

$205M21%

Asia Pacific

$82M8%

CANADA

$37M4%